Memory T cells are not identical with naive T cells: they have surface markers expressed at different levels, they are more capable in handling intense triggering, and they mount a more effective anamnestic immune response. The experiments we propose aim at understanding the basic mechanisms that lead to the acquisition of memory in T cells, the biology of the activation of typical memory T cells in a secondary immune response and the control of the size of the memory T cell pool. 1. Using a panel of memory T cell clones specific for the same antigen, we will correlate their level of Ca2+ sensitivity with their functional and phenotypic characteristics. This analysis should also lead to the identification of cells that represent intermediate stages in the transition from naive to memory T cells. We will investigate, with the help of H-Y specific TCR transgenic mice, whether the ability to down regulate high levels of intracytoplasmic Ca2+ is a unique property of CD4 memory T cells, or whether CD8 memory T cells also exhibit such a capability. 2. We will determine whether CIF and/or the association between CD28 and PI 3-K are involved in the differential regulation of [Ca2+]I in naive and memory T cells. We will investigate the effect of TCR-induced zeta-cytoskeleton association in naive and memory T cells and determine in these cells in influence of TCR-induced integrin activation. Using real time fluorescence imaging microscopy, we will analyze, at the single cell level, the fluctuations of [Ca2+]I following activation. 3. We will determine whether the recruitment of a T cell into the high Ca2+ resistant memory pool is influenced by the type of T precursor (fetal versus adult) from which the T cell is derived. We will determine whether the Ca2+ resistant phenotype associated with memory cells in induced or precedes encounter with antigen. 4. To further understand the molecular basis of memory acquisition, we will attempt to identify new candidate molecules which are responsible for the different functional properties observed between naive and memory T cells.

Project Start
1999-12-01
Project End
2001-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
15
Fiscal Year
2000
Total Cost
$167,178
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Ruiz-Moreno, Juan Sebastian; Hamann, Lutz; Jin, Lei et al. (2018) The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans. Infect Immun 86:
Liu, Haolin; Wang, Chao; Lee, Schuyler et al. (2018) Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7. Sci Rep 8:3275
Rubtsova, Kira; Rubtsov, Anatoly V; Thurman, Joshua M et al. (2017) B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest 127:1392-1404
Getahun, Andrew; Wemlinger, Scott M; Rudra, Pratyaydipta et al. (2017) Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med 214:931-941
Liu, Haolin; Wang, Chao; Lee, Schuyler et al. (2017) Clipping of arginine-methylated histone tails by JMJD5 and JMJD7. Proc Natl Acad Sci U S A 114:E7717-E7726
Lang, Julie; Ota, Takayuki; Kelly, Margot et al. (2016) Receptor editing and genetic variability in human autoreactive B cells. J Exp Med 213:93-108
Noges, Laura E; White, Janice; Cambier, John C et al. (2016) Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines. J Immunol 197:1221-30
Packard, Thomas A; Smith, Mia J; Conrad, Francis J et al. (2016) B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes. J Clin Med 5:
Morton, J Jason; Bird, Gregory; Refaeli, Yosef et al. (2016) Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap. Cancer Res 76:6153-6158
Getahun, Andrew; Beavers, Nicole A; Larson, Sandy R et al. (2016) Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J Exp Med 213:751-69

Showing the most recent 10 out of 297 publications